Maximilian Posch

基本信息

浏览量：221

职业迁徙

个人简介

Skills and Expertise
Heart Failure
Echocardiography
Cardiac Function
Cardiovascular Medicine
Clinical Cardiology
Pharmaceutical Development
Atrial Fibrillation
Genetics
Hypertension
Myocardial Infarction

研究兴趣

论文共 80 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Phase 1 Trials of Gatralimab, a Next-Generation Humanized Anti-CD52 Monoclonal Antibody, in Participants with Progressive Multiple Sclerosis

Fredrik N. Albach,Christian Geier,Christian Keicher,Maximilian G. Posch, Stephan J. Schreiber, Gerald Grütz, Levent Akyüz,Xiaodong Luo,Annaig Le-Halpere,Philippe Truffinet,Frank Wagner

Neurology and Therapypp.1-19, (2024)

引用0浏览0WOS引用

Depression, Anxiety, and Quality of Life As Predictors of Rehospitalization in Patients with Chronic Heart Failure

Jovan Veskovic,Mina Cvetkovic,Elvis Tahirovic,Marija Zdravkovic,Svetlana Apostolovic,Dragana Kosevic,Goran Loncar,Danilo Obradovic,Dragan Matic,Aleksandra Ignjatovic,Tatjana Cvetkovic,Maximilian G. Posch,Sara Radenovic,Arsen D. Ristić, Danilo Dokic,Nenad Milošević, Natasa Panic,Hans-Dirk Düngen

BMC CARDIOVASCULAR DISORDERSno. 1 (2023)

引用7浏览0WOS引用

First-in-Human Study of the Safety, Pharmacokinetics, and Pharmacodynamics of MHV370, a Dual Inhibitor of Toll-Like Receptors 7 and 8, in Healthy Adults

Tamas Shisha,Maximilian G. Posch, Jeanette Lehmann,Roland Feifel,Tobias Junt,Stuart Hawtin, Jens Schuemann,Alexandre Avrameas,Rambabu Danekula, Patrycja Misiolek,Richard Siegel,Peter Gergely

EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICSno. 5 (2023): 553-566

引用5浏览0WOS引用

Safety and Biological Activity of Rozibafusp Alfa, a Bispecific Inhibitor of Inducible Costimulator Ligand and B Cell Activating Factor, in Patients with Rheumatoid Arthritis: Results of a Phase 1b, Randomized, Double‐Blind, Placebo‐Controlled, Multiple Ascending Dose Study

Lubna Abuqayyas,Laurence E. Cheng, Marcia Teixeira dos Santos,Barbara A. Sullivan,Norma Ruiz-Santiago,Hui Wang,Yanchen Zhou,Vishala Chindalore,Stanley Cohen,Alan J. Kivitz,Maximilian G. Posch,Jane R. Parnes

ACR Open Rheumatology（2022）

引用5浏览0WOS引用

An Open-Label Phase 2a Study Investigating the Efficacy and Safety of a Cathepsin S Inhibitor in Patients with Moderate-to-severe Psoriasis

Stephan D. Gadola, Petra Farber,Maximilian G. Posch,Sandra Nagel, Filippo Canducci

Journal of the American Academy of Dermatology（2021）

引用2浏览0WOS引用

674-P: Efficacy and Safety of Cotadutide, a Dual GLP-1 and Glucagon Receptor Agonist in Patients with T2DM and DKD

Victoria E. Parker,Thuong Hoang,Heike Schlichthaar,Fraser W. Gibb,Barbara Wenzel,Maximilian G. Posch,Yi-Ting Chang,Marcella Petrone,Lars Hansen,Philip Ambery,Hiddo L. Heerspink,Rory J. Mccrimmon,Lutz Jermutus

DIABETES（2021）

引用0浏览0引用

Ianalumab (VAY736) in Primary Sjögren's Syndrome: Assessing Disease Activity Using Multi-Modal Ultrasound

T. Diekhoff,T. Fischer,Q. Schefer,M. G. Posch,T. Doerner,D. Laurent,Y. Li,F. D. Wagner,S. J. Oliver

Clinical and Experimental Rheumatology（2020）

引用6浏览0WOS引用

Efficacy, Safety, and Mechanistic Insights of Cotadutide a Dual Receptor Glucagon-Like Peptide-1 and Glucagon Agonist

Victoria E. R. Parker,Darren Robertson,Tao Wang,David C. Hornigold,Marcella Petrone,Aidan T. Cooper,Maximilian G. Posch,Tim Heise,Leona Plum-Moerschel,Heike Schlichthaar,Beate Klaus,Philip D. Ambery,Juris J. Meier,Boaz Hirshberg

The Journal of Clinical Endocrinology & Metabolism（2019）

引用85浏览0WOS引用

1010-P: Effects of MEDI0382, an Oxyntomodulin-Like Peptide with Targeted GLP-1/Glucagon Receptor Activity, on Amino Acids, Ketones, and Free Fatty Acids

Victoria E. Parker,Darren Robertson,Tao Wang,David C. Hornigold,Maximilian G. Posch,Leona Plum-Moerschel,Juris J. Meier,Heike Schlichthaar,Beate M. Klaus,Lutz Jermutus,Philip Ambery,Boaz Hirshberg

DIABETES (2019)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

Chief Medical Officer

论文共 80 篇作者统计合作学者相似作者